Key result
Curcuma longa extracts completely abolished the 50% mortality induced by doxorubicin and significantly reduced markers of cardiac injury such as CK-MB and LDH in rats.
Why the study?
Does Curcuma longa extract prevent doxorubicin-induced cardiotoxicity in rats?
Does Curcuma longa extract prevent doxorubicin-induced cardiotoxicity in rats?
Curcuma longa extracts protect against doxorubicin-induced cardiotoxicity in rats by reducing oxidative stress and preserving antioxidant enzyme activities.
Answers are grounded in this paper and cite their sources.
Should not change doxorubicin cardiotoxicity management; hypothesis-generating in rats and leaves open human translation.
This study was designed to investigate the possible mechanisms whereby Curcuma longacould protect against cardiotoxicity induced by doxorubicin. Administration of doxorubicin (15 mg/kg i.p.) induced cardiomyopathy manifested by significant elevation in serum creatine kinase MB (Ck-MB) and lactate dehydrogenase (LDH) activities. In addition, cardiotoxicity was further confirmed by significant increase in each of serum and cardiac malondialdehyde (MDA) level, serum iron and nitric oxide concentrations, cardiac calcium level, catalase and glucose-6 phosphate dehydrogenase activities as well as by the noticeable reduction in cardiac total antioxidant capacity, vitamin C levels and blood glutathione (GSH) concentration. Oral administration of Curcuma longa ethanolic or water extract (200 mg/kg) prior to doxorubicin produced a significant protection which was evidenced by significant reduction in mortality, CK-MB and LDH -activities. Moreover, they significantly increased GSH markedly, decreased cardiac calcium, and cardiac and serum MDA. In addition, both extracts significantly reduced serum nitric oxide, increased cardiac ascorbic acid, and ameliorated the antioxidant enzymes activities. In conclusion, Curcuma longa extracts renders resiliency against doxorubicin cardiotoxicity due to their contents of polyphenolic compounds that might serve as novel adjuvant therapy with doxorubicin. Key words: Curcume longa L., doxorubicin, cardiotoxicity, antioxidants.
No takes yet. Share an insight, caveat, or question.
El-Sayed et al. (2011) studied Doxorubicin-induced cardiotoxicity (n=96). Curcuma longa L. extracts (ethanolic or water) vs. Doxorubicin alone was evaluated on Mortality rate (p=<0.05). Curcuma longa extracts completely abolished the 50% mortality induced by doxorubicin and significantly reduced markers of cardiac injury such as CK-MB and LDH in rats.
Synapse has enriched 10 related papers. Consider them for comparative context: